Alendronate Sodium
NDC 55695-012
Product Information
Alendronate Sodium is a ANDA-approved product labeled by Department Of State Health Services, Pharmacy Branch. Alendronate is used to prevent and treat certain types of bone loss (osteoporosis) in adults. It is supplied as a white product. This product entry covers the primary NDC 55695-012 and its associated package configuration. This profile includes active and inactive ingredient UNII references and FDA labeling data.
Primary Identification
Labeler & Regulatory Data
Marketing Timeline
Product Characteristics
AN70
Code Structure Chart
Product Details
What is NDC 55695-012?
What are the uses of this product?
Which are the associated UNII Codes?
The UNII codes for the active ingredients in this product are:
- ALENDRONATE SODIUM (UNII: 2UY4M2U3RA)
- ALENDRONIC ACID (UNII: X1J18R4W8P) (Active Moiety)
Which are the Inactive Ingredients associated UNII Codes?
The inactive ingredients are all the component of a medicinal product OTHER than the active ingredient(s). The acronym "UNII" stands for “Unique Ingredient Identifier” and is used to identify each inactive ingredient present in a product. The UNII codes for the inactive ingredients in this product are:
- CELLULOSE, MICROCRYSTALLINE (UNII: OP1R32D61U)
- LACTOSE MONOHYDRATE (UNII: EWQ57Q8I5X)
- CROSCARMELLOSE SODIUM (UNII: M28OL1HH48)
- MAGNESIUM STEARATE (UNII: 70097M6I30)
What is the NDC to RxNorm Crosswalk for this product?
- RxCUI: 904431 - alendronate sodium 70 MG Oral Tablet
- RxCUI: 904431 - alendronic acid 70 MG Oral Tablet
- RxCUI: 904431 - alendronic acid 70 MG (as alendronate sodium 91.4 MG) Oral Tablet
* Please review the full disclaimer at the bottom of this page.